Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol.
Fei ChenZoltán NovákChristian DanneckerCtirad MokrášLong SuiYouzhong ZhangZhixue YouLing HanJinghe LangPeter HillemannsPublished in: BMJ open (2022)
NCT04484415; clinicaltrials.gov.